Bussink J - Search Results

1

Spatial relationship of phosphorylated epidermal growth factor receptor and activated AKT in head and neck squamous cell carcinoma.

Nijkamp MM, Hoogsteen IJ, Span PN, Takes RP, Lok J, Rijken PF, van der Kogel AJ, Bussink J, Kaanders JH. Nijkamp MM, et al. Among authors: bussink j. Radiother Oncol. 2011 Oct;101(1):165-70. doi: 10.1016/j.radonc.2011.06.022. Epub 2011 Jul 19. Radiother Oncol. 2011. PMID: 21775008

2

Pharmacology and toxicity of nicotinamide combined with domperidone during fractionated radiotherapy.

Bussink J, Stratford MR, van der Kogel AJ, Folkes LK, Kaanders JH. Bussink J, et al. Radiother Oncol. 2002 Jun;63(3):285-91. doi: 10.1016/s0167-8140(02)00072-5. Radiother Oncol. 2002. PMID: 12142092

3

Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas.

Ljungkvist AS, Bussink J, Rijken PF, Kaanders JH, van der Kogel AJ, Denekamp J. Ljungkvist AS, et al. Among authors: bussink j. Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):215-28. doi: 10.1016/s0360-3016(02)02938-3. Int J Radiat Oncol Biol Phys. 2002. PMID: 12182995

4

Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.

Kaanders JH, Wijffels KI, Marres HA, Ljungkvist AS, Pop LA, van den Hoogen FJ, de Wilde PC, Bussink J, Raleigh JA, van der Kogel AJ. Kaanders JH, et al. Among authors: bussink j. Cancer Res. 2002 Dec 1;62(23):7066-74. Cancer Res. 2002. PMID: 12460928 Clinical Trial.

5

ARCON: a novel biology-based approach in radiotherapy.

Kaanders JH, Bussink J, van der Kogel AJ. Kaanders JH, et al. Among authors: bussink j. Lancet Oncol. 2002 Dec;3(12):728-37. doi: 10.1016/s1470-2045(02)00929-4. Lancet Oncol. 2002. PMID: 12473514 Review.

6

Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers.

Bussink J, Kaanders JH, van der Kogel AJ. Bussink J, et al. Radiother Oncol. 2003 Apr;67(1):3-15. doi: 10.1016/s0167-8140(03)00011-2. Radiother Oncol. 2003. PMID: 12758235 Review.

7

Clinical studies of hypoxia modification in radiotherapy.

Kaanders JH, Bussink J, van der Kogel AJ. Kaanders JH, et al. Among authors: bussink j. Semin Radiat Oncol. 2004 Jul;14(3):233-40. doi: 10.1016/j.semradonc.2004.04.002. Semin Radiat Oncol. 2004. PMID: 15254866 Review.

8

Effects of nicotinamide and carbogen in different murine colon carcinomas: immunohistochemical analysis of vascular architecture and microenvironmental parameters.

van Laarhoven HW, Bussink J, Lok J, Punt CJ, Heerschap A, van Der Kogel AJ. van Laarhoven HW, et al. Among authors: bussink j. Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):310-21. doi: 10.1016/j.ijrobp.2004.05.014. Int J Radiat Oncol Biol Phys. 2004. PMID: 15337570

9

Irradiation combined with SU5416: microvascular changes and growth delay in a human xenograft glioblastoma tumor line.

Schuuring J, Bussink J, Bernsen HJ, Peeters W, van Der Kogel AJ. Schuuring J, et al. Among authors: bussink j. Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):529-34. doi: 10.1016/j.ijrobp.2004.09.063. Int J Radiat Oncol Biol Phys. 2005. PMID: 15667976

10

Interleukin-12 has no effect on vascular density, perfusion, hypoxia and proliferation of an implanted human squamous cell carcinoma xenograft tumour despite up-regulation of ICAM-1.

van Herpen CM, Bussink J, van der Kogel AJ, Peeters WJ, van der Voort R, van Schijndel A, de Wilde PC, Adema GJ, de Mulder PH. van Herpen CM, et al. Among authors: bussink j. Anticancer Res. 2005 Mar-Apr;25(2A):1015-21. Anticancer Res. 2005. PMID: 15868941 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters